Resources Contact Us Home
Immunological composition of measles virus utilizing recombinant poxvirus

Image Number 12 for United States Patent #5759841.

What is described is a recombinant poxvirus, such as vaccinia virus or canarypox virus, containing foreign DNA from Morbillivirus. In one embodiment, the foreign DNA is expressed in a host by the production of a measles virus glycoprotein. In another embodiment, the foreign DNA is expressed in a host by the production of at least two measles virus glycoproteins. What is also described is a vaccine containing the recombinant poxvirus for inducing an immunological response in a host animal inoculated with the vaccine. By the present invention, cross-protection of dogs against canine distemper is obtained by inoculating the dog with the recombinant poxvirus.

  Recently Added Patents
Organic compounds
Intake parameter-calculating device for internal combustion engine and method of calculating intake parameter
Illuminating device
Headset, terminal, and method capable of switching headset mode
Adaptive contact window wherein the probability that an answering user/expert will respond to a question corresponds to the answering users having response rates that are based on the time of
  Randomly Featured Patents
Portage device
Rework method for wafers that trigger WCVD backside alarm
Cementing tool and method
Foldable playpen
Plastic molding apparatus for equalizing flow pressure and flow velocity of plastic melt
7-Acylamino-3-[1-[2-(carboxymethylamino]ethyl) tetrazol-5-ylthiomethyl]-3-cephem-4-carboxylic acids
Informational terminal unit
Device and method for protecting against oxidation of a conductive layer in said device
Semiconductor device
Mirrorback coating